62 related articles for article (PubMed ID: 1745982)
21. [Cytogenetic changes in benign thyroid gland hyperplasias and adenomas correlated with histology].
Belge G; Roque L; Thode B; Fonseca E; Soares J; Clode A; Bartnitzke S; Castedo S; Bullerdiek J
Verh Dtsch Ges Pathol; 1997; 81():151-6. PubMed ID: 9474866
[TBL] [Abstract][Full Text] [Related]
22. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
23. DNA copy number changes in thyroid carcinoma.
Hemmer S; Wasenius VM; Knuutila S; Franssila K; Joensuu H
Am J Pathol; 1999 May; 154(5):1539-47. PubMed ID: 10329606
[TBL] [Abstract][Full Text] [Related]
24. SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.
Moraitis D; Karanikou M; Liakou C; Dimas K; Tzimas G; Tseleni-Balafouta S; Patsouris E; Rassidakis GZ; Kouvaraki MA
Surgery; 2014 Dec; 156(6):1542-8; discussion 1548-9. PubMed ID: 25456951
[TBL] [Abstract][Full Text] [Related]
25. Genetic heterogeneity of benign thyroid lesions. Static and flow cytometry, karyotyping and in situ hybridization analysis.
Ferrer-Roca O; Pérez-Gómez JA; Cigudosa JC; Gómez E; Estévez M
Anal Cell Pathol; 1998; 16(2):101-10. PubMed ID: 9692684
[TBL] [Abstract][Full Text] [Related]
26. Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.
Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C
Int J Oncol; 2005 Jan; 26(1):141-9. PubMed ID: 15586234
[TBL] [Abstract][Full Text] [Related]
27. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.
Herrmann MA; Hay ID; Bartelt DH; Ritland SR; Dahl RJ; Grant CS; Jenkins RB
J Clin Invest; 1991 Nov; 88(5):1596-604. PubMed ID: 1939648
[TBL] [Abstract][Full Text] [Related]
28. Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas.
Wang W; Wang H; Teng X; Wang H; Mao C; Teng R; Zhao W; Cao J; Fahey TJ; Teng L
Hum Pathol; 2010 Sep; 41(9):1299-309. PubMed ID: 20471663
[TBL] [Abstract][Full Text] [Related]
29. Hürthle cell tumors: applying molecular markers to define a new management algorithm.
Maxwell EL; Palme CE; Freeman J
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):54-8. PubMed ID: 16415430
[TBL] [Abstract][Full Text] [Related]
30. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetic studies on 19 papillary thyroid carcinomas.
Antonini P; Vénuat AM; Caillou B; Berger R; Schlumberger M; Bernheim A; Parmentier C
Genes Chromosomes Cancer; 1992 Oct; 5(3):206-11. PubMed ID: 1384672
[TBL] [Abstract][Full Text] [Related]
32. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
33. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
Nikiforova MN; Kimura ET; Gandhi M; Biddinger PW; Knauf JA; Basolo F; Zhu Z; Giannini R; Salvatore G; Fusco A; Santoro M; Fagin JA; Nikiforov YE
J Clin Endocrinol Metab; 2003 Nov; 88(11):5399-404. PubMed ID: 14602780
[TBL] [Abstract][Full Text] [Related]
34. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex).
Stratakis CA; Jenkins RB; Pras E; Mitsiadis CS; Raff SB; Stalboerger PG; Tsigos C; Carney JA; Chrousos GP
J Clin Endocrinol Metab; 1996 Oct; 81(10):3607-14. PubMed ID: 8855810
[TBL] [Abstract][Full Text] [Related]
36. Hürthle cell tumors: a twenty-five-year experience.
Arganini M; Behar R; Wu TC; Straus F; McCormick M; DeGroot LJ; Kaplan EL
Surgery; 1986 Dec; 100(6):1108-15. PubMed ID: 3787466
[TBL] [Abstract][Full Text] [Related]
37. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma.
Kim TY; Kim WB; Song JY; Rhee YS; Gong G; Cho YM; Kim SY; Kim SC; Hong SJ; Shong YK
Clin Endocrinol (Oxf); 2005 Nov; 63(5):588-93. PubMed ID: 16268813
[TBL] [Abstract][Full Text] [Related]
38. Cytochemical assessments of the nuclear DNA distribution pattern by means of image and flow cytometry in thyroid neoplasms and in non-neoplastic thyroid lesions. A comparative methodological study.
Wallin G; Askensten U; Bäckdahl M; Grimelius L; Lundell G; Auer G
Acta Chir Scand; 1989; 155(4-5):251-8. PubMed ID: 2800873
[TBL] [Abstract][Full Text] [Related]
39. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
[TBL] [Abstract][Full Text] [Related]
40. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
